News Column

ONCOMED PHARMACEUTICALS INC FILES (8-K) Disclosing Submission of Matters to a Vote of Security Holders

June 19, 2014

Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 18, 2014, OncoMed Pharmaceuticals, Inc. (the "Company") held its 2014 Annual Meeting of Stockholders (the "2014 Annual Meeting"). At the 2014 Annual Meeting, the stockholders of the Company voted on the following proposals, each of which is described in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 28, 2014, as supplemented (the "Proxy Statement"):

Proposal 1: Election of Directors.

The stockholders elected the following individuals to the Company's Board of Directors: Nominee For Withheld Broker Non-Vote Uncast Elisha P. Gould III 19,762,442 1,621,735 2,528,686 0 Michael S. Wyzga 21,337,077 47,100 2,528,686 0

Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm.

The stockholders ratified and approved the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2014.

For Against Abstain Broker Non-Votes Uncast 23,852,669 23,387 36,807 0 0


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters